Stockreport

Atai Life Sciences (ATAI): Evaluating Valuation After FDA Breakthrough Therapy Designation for BPL-003 [Yahoo! Finance]

Atai Beckley N.V - Common Shares  (ATAI) 
US:NASDAQ Investor Relations: ir.atai.net.cn
PDF BPL-003, their investigational nasal spray for treatment-resistant depression. This recognition accelerates the path to potential approval and highlights excitement abou [Read more]